Status:

COMPLETED

An Observational Study of Follitropin Alpha Biosimilar: the Real-world Data

Lead Sponsor:

IVFarma LLC

Collaborating Sponsors:

Institute for Preventive and Social Medicine

Conditions:

Reproductive Issues

Reproductive Disorder

Eligibility:

FEMALE

20-43 years

Brief Summary

Aim to investigate the efficacy of follitropin alpha biosimilar therapy (Primapur®) in nonselected real-world population.

Detailed Description

A retrospective observational anonymized cohort study of follitropin alpha biosimilar (Primapur®) as a pre-filled pen injector with a dose adjustment of 5 IU, aimed to investigate its efficacy and saf...

Eligibility Criteria

Inclusion

  • Women with established causes of infertility and indications for the use of ART methods, according to the Order of the Ministry of Health of the Russian Federation "On the use of assisted reproductive technologies, contraindications and limitations to their use" No. 107 n dated August 30, 2012.
  • Infertility due to female and/or male factor.
  • Presence of ovaries accessible for aspiration of follicles.
  • Anatomical and functional capability of uterus to bear pregnancy.

Exclusion

  • Women with established contraindications to the use of ART methods, according to the Order of the Ministry of Health of the Russian Federation "On the use of assisted reproductive technologies, contraindications and limitations to their use" No. 107 n dated August 30, 2012.
  • Presence of pregnancy
  • Hypersensitivity to follitropin alfa or excipients.
  • Ovarian cysts (not associated with polycystic ovarian syndrome), uterine hemorrhage of unclear etiology
  • Premature ovarian failure
  • Presence of clinically significant systemic disease
  • Presence of chronic cardiovascular, hepatic, renal or pulmonary disease
  • Neoplasia
  • Narcomania, alcoholism

Key Trial Info

Start Date :

January 12 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 20 2021

Estimated Enrollment :

5484 Patients enrolled

Trial Details

Trial ID

NCT04854707

Start Date

January 12 2020

End Date

January 20 2021

Last Update

October 22 2021

Active Locations (35)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 9 (35 locations)

1

Center for reproductive medicine, Barnaul

Barnaul, Russia

2

Center for reproductive medicine, Irkutsk

Irkutsk, Russia

3

Clinic "Mother and Child" Kazan

Kazan', Russia

4

Clinic "Mother and Child" Kostroma

Kostroma, Russia